Ruxolitinib: Overview and Availability at Medicapharma
Ruxolitinib is a highly effective medication primarily used for the treatment of myelofibrosis, polycythemia vera, and graft-versus-host disease (GVHD). As a selective Janus kinase (JAK) 1 and JAK 2 inhibitor, Ruxolitinib works by reducing inflammation and abnormal cell proliferation, which are hallmark issues in these conditions. This targeted therapy significantly alleviates symptoms such as spleen enlargement, fatigue, and night sweats, improving the quality of life for patients.
Visit:https://www.medicapharma.com/s....hop/oncology/ruxolit
Synes godt om
Kommentar
Del
